Detection of Epigenetic Field Defects Using a Weighted Epigenetic Distance-Based Method

Area of Science:

• Epigenetics
• Cancer Biology
• Bioinformatics

Background:

• Early detection of cancer is crucial and often relies on identifying epigenetic alterations, such as DNA methylation changes.
• These early methylation alterations can be infrequent and appear as outlier samples, posing a challenge for traditional analysis methods.

Purpose of the Study:

• To develop and validate a novel weighted epigenetic distance-based method for identifying early cancer-related epigenetic field defects.
• To improve the detection power for subtle epigenetic signals that may be missed by conventional site-level analyses.

Main Methods:

• Developed a weighted epigenetic distance metric to quantify methylation similarity/dissimilarity between samples across multiple CpGs.
• Incorporated weights to prioritize informative CpGs (signal) and down-weight noisy CpGs.
• Considered both differential methylation (DM) and differential variability (DV) signals in constructing epigenetic distances.
• Compared the proposed method against non-weighted approaches and standard epigenome-wide association studies (EWAS) using simulations and real-world breast cancer data.

Main Results:

• The weighted epigenetic distance method demonstrated superior performance over non-weighted methods and site-level EWAS in simulation studies.
• Application to breast cancer data identified novel epigenetic field defects missed by EWAS.
• These novel findings were associated with breast cancer progression and partially replicated.

Conclusions:

• The weighted epigenetic distance method is a powerful tool for detecting subtle epigenetic field defects indicative of early cancer.
• This approach enhances the identification of potential cancer biomarkers and aids in understanding cancer progression.
• The method offers improved study power by accumulating weak methylation signals across multiple CpGs.